Connor Iapoce is an associate editor for HCPLive and joined the MJH Life Sciences team in April 2021. He graduated from The College of New Jersey with a degree in Journalism and Professional Writing. He enjoys listening to records, going to concerts, and playing with his cat Squish. You can reach him at ciapoce@mjhlifesciences.com.
Diabetic Microvascular Disease Associated with Left Ventricular Hypertrophy in T2D
July 2nd 2023After adjusting for potential confounding factors, patients with microvascular diseases, particularly diabetic retinopathy, and diabetic kidney disease, were found to have a greater possibility of left ventricular hypertrophy.
Read More
Phase 1/2 Data Show Potential of VX-880 for Insulin Independence in T1D
June 24th 2023New results from the ongoing clinical trial of VX-880 suggested all patients with T1D treated with the novel stem cell-derived islet cell therapy showed restored endogenous insulin secretion and improved glycemic control.
Read More
10 Years of Obesity: A Decade of Advancement and Challenges
June 23rd 2023To celebrate the 10-year anniversary of the AMA recognizing obesity as a disease, this feature leverages the perspective of key opinion leaders to examine what has changed and what has not since the AMA's declaration in June 2013.
Read More
SGLT2 Inhibitors Benefit CV Outcomes Across Heart Failure, T2D, CKD Populations
June 21st 2023A meta-analysis of 13 trials suggests SGLT2 inhibitors reduced heart failure events and cardiovascular death across these patient populations, with consistent effects in patients with varying disease combinations.
Read More